Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed CFO
Appointed director
|
|
RELMADA THERAPEUTICS, INC. (RLMD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/27/2014 |
8-K
| Appointed CFO|
Docs:
|
"Share Exchange Agreement, by and among Camp Nine, Inc., Relmada Therapeutics, Inc., and the stockholders of Relmada Therapeutics, Inc",
"(i) Amended and Restated Certificate of Incorporation of Relmada Therapeutics, Inc",
"(i) Amended and Restated Certificate of Incorporation of Relmada Therapeutics, Inc",
"By-laws of Camp Nine, Inc",
"By-laws of Relmada Therapeutics, Inc",
"Form of Warrants to Purchase Common Stock issued in 2012 and 2013 in connection with Relmada Therapeutics, Inc. Series A Preferred Stock",
"Form of Warrants to Purchase Common Stock issued in 2012 and 2013 in connection with Relmada Therapeutics, Inc. 8% Senior Subordinated Promissory Notes",
"Form of A Warrant dated May __, 2014 issued to investors by Relmada Therapeutics, Inc",
"Form of B Warrant dated May __, 2014 issued to investors by Relmada Therapeutics, Inc",
"(i) Option to Sergio Traversa to purchase common stock of Relmada Therapeutics, Inc" |
|
|
|